prana-biotechnology-s-phase-ii-trial-for-huntington-reach2hd-and-alzheimer-s-disease-imagine-shows-that-37-percent-have-well-tolerated-and-are-demonstrating-pleasing-retention-rates-and-compliance

Prana Alzheimer's trial shows +ve results

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 1 Comment

Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials for Huntington disease and Alzheimer's disease.... Read more

oxycodone-patch-resumes-clinical-development

Oxycodone patch resumes clinical development

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian drug delivery technology company, Phosphagenics, will be returning to the clinic with its oxycodone TPM transdermal patch. The company... Read more

oramed-gets-japanese-patent-for-protein-delivery

Oramed gets Japanese patent for protein delivery

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, has received approval for a key patent by the Japanese Patent Office. The patent,... Read more

alchemia-cancer-drug-gets-patent-protection

Alchemia cancer drug gets US patent protection

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Alchemia has been granted a further patent term adjustment for a key HyACT US patent, as well as an important additional patent further protecting its... Read more

dr

DRL launches Alchemia thrombosis generic in India

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic anti-coagulant product fondaparinux in India.... Read more

agenix-seeks-china-sfda-nod-for-hepatitis-candidate

Agenix seeks China SFDA nod for hepatitis candidate

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Drug and diagnostic company Agenix announced that it was on track to submit a new drug clinical trial application with China's State Food and Drug Administration... Read more

phospagenics-nippon-zoki-to-develop-pain-drug

Phospagenics, Nippon Zoki to develop pain drug

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian drug delivery technology company Phosphagenics has extended its collaboration with its high caliber Japanese partner, Nippon Zoki Pharmaceutical,... Read more

allied-applies-for-heart-patch-approval-in-us

Allied applies for heart patch approval in US

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Allied Healthcare has lodged its Premarket Notification 510(k) Submission for CardioCel in the US. The FDA 510(K) submission is a major step in Allied's... Read more

fovia-medical-and-contrast-imaging-to-image-cancer-cells-using-high-definition-volume-rendering

Fovia to image cancer cells using HD volume

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Fovia Medical, a world leader in volume rendering technology, and Contrast Imaging, a leading Australian provider of process-effective radiology solutions,... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X